BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 12691105)

  • 61. Draft additional protocol to the Convention on Human Rights and Biomedicine, on biomedical research.
    Council of Europe, Steering Committee on Bioethics (CDBI)
    J Int Bioethique; 2004 Mar; 15(1):107-22. PubMed ID: 15835068
    [No Abstract]   [Full Text] [Related]  

  • 62. Conflict of interest in biomedical research.
    Blumenthal D
    Health Matrix Clevel; 2002; 12(2):377-92. PubMed ID: 12430361
    [No Abstract]   [Full Text] [Related]  

  • 63. Restrictions on business relationships with industries, and their unintended adverse consequences.
    Sataloff RT
    Ear Nose Throat J; 2009 May; 88(5):904-8. PubMed ID: 19444783
    [No Abstract]   [Full Text] [Related]  

  • 64. On the need for probity when physicians interact with industry.
    Scott IA
    Intern Med J; 2006 Apr; 36(4):265-9. PubMed ID: 16640747
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Financial conflicts of interest among ASCO annual meeting abstract authors, speakers, and planners.
    Johnston KL; Go RS
    J Natl Cancer Inst; 2007 Sep; 99(18):1415-6. PubMed ID: 17848676
    [No Abstract]   [Full Text] [Related]  

  • 66. Industry and medicine: conflicting interests and the power of money.
    Popovsky MA; Garcia N
    Transfusion; 2007 Jun; 47(6):1098-9. PubMed ID: 17524103
    [No Abstract]   [Full Text] [Related]  

  • 67. Justice in the application of science: beyond fair benefits.
    London AJ
    Am J Bioeth; 2010 Jun; 10(6):54-6. PubMed ID: 20526976
    [No Abstract]   [Full Text] [Related]  

  • 68. Is any medical research population not vulnerable?
    Leavitt FJ
    Camb Q Healthc Ethics; 2006; 15(1):81-8. PubMed ID: 16529310
    [No Abstract]   [Full Text] [Related]  

  • 69. The impact of escalating regulatory requirements on the conduct of clinical research.
    Gordon BG; Kessinger A; Mann SL; Prentice ED
    Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Investigator, IRB and institutional financial conflicts in interest in human-subject research: past, present and future.
    Barnes M; Florencio PS
    Seton Hall Law Rev; 2003; 32(3):525-60. PubMed ID: 12741411
    [No Abstract]   [Full Text] [Related]  

  • 71. Financial relationships between research and pharmaceutical/biotech companies: disclosure is imperative.
    Caughey AB; Urato AC
    Am J Obstet Gynecol; 2007 Jan; 196(1):e13; author reply e13-4; discussion e14. PubMed ID: 16959207
    [No Abstract]   [Full Text] [Related]  

  • 72. Science on trial: conflicts of interest jeopardize scientific integrity and public health.
    Krimsky S
    Genewatch; 2003; 16(5):3-6. PubMed ID: 15025119
    [No Abstract]   [Full Text] [Related]  

  • 73. Expert opinion and controversies in musculoskeletal and sports medicine: conflict of interest.
    Standaert CJ; Schofferman JA; Herring SA
    Arch Phys Med Rehabil; 2009 Oct; 90(10):1647-51. PubMed ID: 19801051
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Conflict of interest--or conflict of priorities?
    Nabel EG
    N Engl J Med; 2006 Nov; 355(22):2365-7. PubMed ID: 17135592
    [No Abstract]   [Full Text] [Related]  

  • 75. Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research.
    Jagsi R; Sheets N; Jankovic A; Motomura AR; Amarnath S; Ubel PA
    Cancer; 2009 Jun; 115(12):2783-91. PubMed ID: 19434666
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A comparison of journal instructions regarding institutional review board approval and conflict-of-interest disclosure between 1995 and 2005.
    Rowan-Legg A; Weijer C; Gao J; Fernandez C
    J Med Ethics; 2009 Jan; 35(1):74-8. PubMed ID: 19103950
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Independent investigators and for-profit companies. Guidelines for biomedical scientists considering funding by industry.
    Chren MM
    Arch Dermatol; 1994 Apr; 130(4):432-7. PubMed ID: 8166481
    [No Abstract]   [Full Text] [Related]  

  • 78. [Conflicts of interest in financing medical research].
    Uusitupa M
    Duodecim; 2003; 119(15):1405-7. PubMed ID: 14502815
    [No Abstract]   [Full Text] [Related]  

  • 79. The right of subjects to see the protocol.
    Veatch RM
    IRB; 2002; 24(5):6-8. PubMed ID: 12737168
    [No Abstract]   [Full Text] [Related]  

  • 80. Clinical trials. Proposed rules aim to curb financial conflicts of interest.
    Kaiser J
    Science; 2002 Jan; 295(5553):246-7. PubMed ID: 11786611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.